Printer Friendly

CYTOPROBE ANNOUNCES APPROVAL TO BEGIN TESTING OF DEVICE

 SAN DIEGO, June 10 /PRNewswire/ -- CytoProbe Corp. (NASDAQ: CYTP) announced approval to begin testing of its Intracranial Pressure (ICP) device in human subjects this summer. CytoProbe holds exclusive international and domestic patent rights to the ICP device designed to non-invasively measure intracranial pressure. To date, ICP measurement involves drilling a hole in the skull and the insertion of a filled catheter through the hole and into the cranial cavity. Development of a non-invasive alternative to this method will be a major medical breakthrough.
 The first clinical site is Darmouth-Hitchcock Medical Center in Lebanon, N.H. Dr. Richard Saunders, professor of Neurosurgery at Darmouth and a member of CytoProbe's Medical Advisory Board will be in charge of the clinical trials.
 CytoProbe operates two primary businesses: The exploration and development of oil and gas reserves and the manufacturing and marketing of specialty medical products.
 -0- 6/10/93
 /CONTACT: CytoProbe Corp., 800-543-9401/
 (CYTP)


CO: CytoProbe Corp. ST: California IN: MTC SU:

JB-MF -- SD001 -- 0468 06/10/93 09:04 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 10, 1993
Words:168
Previous Article:UNIVERSITY OF CHICAGO GRADUATE SCHOOL OF BUSINESS AND ARGENTARIA ANNOUNCE THE ESTABLISHMENT OF A EUROPEAN EXECUTIVE M.B.A. PROGRAM
Next Article:U.S. PATENT ISSUES THAT EXPANDS ISIS' PROPRIETARY POSITION IN OLIGONUCLEOTIDE-BASED DRUG MANUFACTURING
Topics:


Related Articles
CYTOPROBE CORP. NAMES NEW PRESIDENT
CYTOPROBE CORP. TO BEGIN ICP CLINICAL TRIALS
CYTOPROBE CORPORATION ANNOUNCES REVERSE STOCK SPLIT
CYTOPROBE CORP. SUBMITS PERSONAL ALARM SYSTEM (PAS) FOR FDA CLEARANCE
CYTOPROBE CORP. ANNOUNCES ADOPTION OF RIGHTS PLAN
CYTOPROBE CORP. ANNOUNCES ADOPTION OF RIGHTS PLAN
CYTOPROBE ANNOUNCES COMMENCEMENT OF TESTING BY NASA AMES RESEARCH CENTER OF A NON-INVASIVE ACOUSTIC DIAGNOSTIC DEVICE TO MEASURE INTRACRANIAL PRESSURE
CYTOPROBE ANNOUNCES COMMENCEMENT OF TESTING BY NASA AMES RESEARCH CENTER OF A NON-INVASIVE ACOUSTIC DIAGNOSTIC DEVICE TO MEASURE INTRACRANIAL PRESSURE
CYTOPROBE CORPORATION ANNOUNCES CLOSING OF $1 MILLION PRIVATE PLACEMENT
MEDICAL DEVICE TECHNOLOGIES, INC. ANNOUNCES NAME CHANGE AT ANNUAL SHAREHOLDERS MEETING

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters